Cover Image
市場調查報告書

冠狀動脈支架市場(傳統金屬支架,藥劑溶出性血管支架,人體可吸收支架)-全球產業分析,市場規模,佔有率,成長,趨勢及預測

Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 302449
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
冠狀動脈支架市場(傳統金屬支架,藥劑溶出性血管支架,人體可吸收支架)-全球產業分析,市場規模,佔有率,成長,趨勢及預測 Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年05月08日 內容資訊: 英文 100 Pages
簡介

本報告提供全球冠狀動脈支架市場相關調查,彙整市場概要和2013∼2019年的預測,各地區趨勢,加入此市場的企業簡介,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 全球冠狀動脈支架市場概要

  • 簡介
  • 推動市場的要素
    • 冠狀動脈疾病的罹患率上升
    • 全世界的肥胖率的上升
    • 高齡人口
  • 阻礙市場的要素
    • 產品成本過高
    • 缺乏有效率的給付系統
    • 造成支架內及晚期支架內血管再阻塞及血栓症的高風險
  • 市場機會
    • 臨床實驗新技術解決患者群的各種未滿足需求
    • 亞太地區,南美,非洲等新興市場上高成長機會
  • 波特五力分析
  • 市場魅力度分析
  • 市場佔有率分析

第4章 各產品市場

  • 概要
  • 傳統金屬支架
  • 藥劑溶出性血管支架
  • 人體可吸收支架

第5章 開發平台概要

  • 概要
  • CORACTO
  • EXCELLA II及EXCELLA BD
  • DESolve Nx及DESolve FIM
  • ZoMaxx I and ZoMaxx II
  • ABSORB STEMI
  • BioFreedom
  • TAXUS PERSEUS
  • BioNIR

第6章 各地區市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 建議

第8章 企業簡介

  • Abbott Laboratories, Inc.
  • amg International GmbH
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cook Medical, Inc.
  • Johnson & Johnson
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • STENTYS SA
  • Terumo Corporation (Japan)

圖表

目錄

This report studies the current as well as future prospects of the coronary stents market globally. The market for coronary stents is categorized into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. Each of the market segments has been extensively analyzed on the basis of their commercial existence, efficacy, sales revenue and geographic presence. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019. The report also provides compounded annual growth rate (CAGR %) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.

The global coronary stents market has been categorized into four geographical regions - North America, Europe, Asia-Pacific, and Rest of the World (RoW). The market sizes and forecasts for each of these regions have been provided for the period 2011 to 2019 along with CAGR (%) for the forecast period 2013 to 2019. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global coronary stents market and future opportunities has been provided in the market overview section. This section of the report also deals with market attractiveness analysis, Porter's five forces analysis and key players' market share analysis in 2012 for the global coronary stents market.

A list of recommendations has been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report also comprises a section on pipeline overview for this market that includes qualitative analysis for various coronary stents currently under phase II, III & IV clinical trials, which are expected to be launched during the forecast period.

The report also profiles major players of the global coronary stents market on the basis of various attributes such as company overview, financial overview, product portfolio, business strategies and recent developments. The major players profiled in this report include Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic, Inc., Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, and C. R. Bard, Inc., Cook Medical, Inc., amg International GmbH, Biotronik SE & Co. KG, Stentys SA and MicroPort Scientific Corporation.

The global coronary stents market is segmented as follows:

Coronary Stents Market, by Product Type

  • Bare Metal Stents
  • Drug Eluting Stents
  • Bio-absorbable Stents

Coronary Stents Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

Chapter 2 - Executive Summary

  • 2.1. Market Snapshot: Global Coronary Stents Market
  • 2.2. Comparative Analysis: Global Coronary Stents Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 - Global Coronary Stents Market Overview

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Increasing Prevalence of Coronary Artery Diseases (CADs)
    • 3.2.2. Rise in Global Obesity Rates
    • 3.2.3. Aging Population
    • 3.2.4. Increasing Uptake of Technologically Advanced Coronary Stents like Bio-absorbable Stents
  • 3.3. Market Restraints
    • 3.3.1. High Product Cost
    • 3.3.2. Lack of Efficient Reimbursement System
    • 3.3.3. High Risk of In-stent and Late-stent Restenosis and Thrombosis
  • 3.4. Market Opportunities
    • 3.4.1. Novel Technologies in Clinical Trials will Address Various Unmet Needs of the Patient Pool
    • 3.4.2. High Growth Opportunities in the Emerging Markets of APAC, LATAM and Africa
  • 3.5. Porter's Five Forces Analysis: Global Coronary Stents Market
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of Substitutes
    • 3.5.4. Threat of New Entrants
    • 3.5.5. Competitive Rivalry
  • 3.6. Market Attractiveness Analysis: Global Coronary Stents Market, by Geography
  • 3.7. Competitive Landscape
    • 3.7.1. Market Share Analysis: Global Coronary Stents Market, 2012 (Value %)

Chapter 4 - Global Coronary Stents Market, by Product Type

  • 4.1. Overview
    • 4.1.1. Coronary Stents: Key Brands by Manufacturer
    • 4.1.2. Global Coronary Stents Market Revenue, by Product Type, 2011 - 2019 (USD Million)
    • 4.1.3. Comparative Analysis: Global Coronary Stents Market, by Product Type, 2012 & 2019 (Value %)
  • 4.2. Bare Metal Stents
    • 4.2.1. Bare Metal Stents: Key Brands by Manufacturer
    • 4.2.2. Global Bare Metal Stents Market Revenue, 2011 - 2019 (USD Million)
  • 4.3. Drug Eluting Stents
    • 4.3.1. Drug Eluting Stents: Key Brands by Manufacturer
    • 4.3.2. Global Drug Eluting Stents Market Revenue, 2011 - 2019 (USD Million)
  • 4.4. Bio-absorbable Stents
    • 4.4.1. Bio-absorbable Stents: Key Brands by Manufacturer
    • 4.4.2. Global Bio-absorbable Stents Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 - Global Coronary Stents Market: Pipeline Overview

  • 5.1. Overview
  • 5.2. CORACTO
  • 5.3. EXCELLA II and EXCELLA BD
  • 5.4. DESolve Nx and DESolve FIM
  • 5.5. ZoMaxx I and ZoMaxx II
  • 5.6. ABSORB STEMI
  • 5.7. BioFreedom
  • 5.8. TAXUS PERSEUS
  • 5.9. BioNIR

Chapter 6 - Global Coronary Stents Market, by Geography

  • 6.1 Overview
    • 6.1.1 Global Coronary Stents Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 6.2 North America
    • 6.2.1 North America Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • 6.4 Asia-Pacific
    • 6.4.1 Asia-Pacific Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • 6.5 Rest of the World (RoW)
    • 6.5.1 RoW Coronary Stents Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 - Recommendations

  • 7.1. Investing in Research and Development of Technologically Advanced Products with Additional Benefits
  • 7.2. Targeting Emerging Markets such as India, China, Brazil, Mexico, Russia and South Africa
  • 7.3. Emphasis on Price Control

Chapter 8 - Company Profiles

  • 8.1. Abbott Laboratories, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategies
    • 8.1.5. Recent Developments
  • 8.2. amg International GmbH
    • 8.2.1. Company Overview
    • 8.2.2. Financial Overview
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategies
    • 8.2.5. Recent Developments
  • 8.3. B. Braun Melsungen AG
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategies
    • 8.3.5. Recent Developments
  • 8.4. Biotronik SE & Co. KG
    • 8.4.1. Company Overview
    • 8.4.2. Financial Overview
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategies
    • 8.4.5. Recent Developments
  • 8.5. Boston Scientific Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Financial Overview
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategies
    • 8.5.5. Recent Developments
  • 8.6. C. R. Bard, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Financial Overview
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategies
    • 8.6.5. Recent Developments
  • 8.7. Cook Medical, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Financial Overview
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategies
    • 8.7.5. Recent Developments
  • 8.8. Johnson & Johnson
    • 8.8.1. Company Overview
    • 8.8.2. Financial Overview
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategies
    • 8.8.5. Recent Developments
  • 8.9. Medtronic, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Financial Overview
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategies
    • 8.9.5. Recent Developments
  • 8.10. MicroPort Scientific Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Financial Overview
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategies
    • 8.10.5. Recent Developments
  • 8.11. STENTYS SA
    • 8.11.1. Company Overview
    • 8.11.2. Financial Overview
    • 8.11.3. Product Portfolio
    • 8.11.4. Business Strategies
    • 8.11.5. Recent Developments
  • 8.12. Terumo Corporation
    • 8.12.1. Company Overview
    • 8.12.2. Financial Overview
    • 8.12.3. Product Portfolio
    • 8.12.4. Business Strategies
    • 8.12.5. Recent Developments

List of Figures

  • FIG. 1: Coronary Stents: Market Segmentation
  • FIG. 2: Global Coronary Stents Market, by Product Type, 2012 (USD Million)
  • FIG. 3: Comparative Analysis: Global Coronary Stents Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 4: Porter's Five Forces Analysis: Global Coronary Stents Market
  • FIG. 5: Market Attractiveness Analysis: Global Coronary Stents Market, by Geography
  • FIG. 6: Market Share by Key Players: Global Coronary Stents Market, 2012 (Value %)
  • FIG. 7: Comparative Analysis: Global Coronary Stents Market, by Product Type, 2012 & 2019 (Value %)
  • FIG. 8: Global Bare Metal Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 9: Global Drug Eluting Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10: Global Bio-absorbable Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11: North America Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12: Europe Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13: Asia-Pacific Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14: RoW Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15: Abbott Laboratories, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 16: B. Braun Melsungen AG: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 17: Boston Scientific Corporation: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 18: C. R. Bard, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 19: Johnson & Johnson: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 20: Medtronic, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 21: MicroPort Scientific Corporation: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 22: STENTYS SA: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 23: Terumo Corporation: Annual Revenue, 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1: Market Snapshot: Global Coronary Stents Market
  • TABLE 2: Coronary Stents: Key Brands by Manufacturer
  • TABLE 3: Global Coronary Stents Market Revenue, by Product Type, 2011 - 2019 (USD Million)
  • TABLE 4: Bare Metal Stents: Key Brands by Manufacturer
  • TABLE 5: Drug Eluting Stents: Key Brands by Manufacturer
  • TABLE 6: Bio-absorbable Stents: Key Brands by Manufacturer
  • TABLE 7: Global Coronary Stents Market Revenue, by Geography, 2011 - 2019 (USD Million)
Back to Top